KEY-T 0.18 BIP.UN-T -0.15 POW-T -0.1 BBD.B-T 1.53 UNH-N -5.61 NTR-T 0.52 TGT-N 1.27
Futuremed Healthcare (FMD-T)
The ultimate 360° Tracker Your financial life in one place, automatically

Futuremed Healthcare (FMD-T)

NEW AI Investor Insights
8 watching

0.00
0.00 (0.00%) 1d
0

Related posts

Nervous markets await Nvidia
PAST TOP PICK

Futuremed Healthcare(FMD-T)

Jun 17, 2011
(A Top Pick July 7/10. Down 10.07%.) Sold his holdings.
Michael Simpson, CFAMichael Simpson, CFA
No
Unlock Rating
$7.740

Stock price when the opinion was issued

biotechnology pharmaceutical
PAST TOP PICK

Futuremed Healthcare(FMD-T)

Apr 07, 2011
(A Top Pick Dec 16/09. Down 14.43%.) Supplies to seniors’ homes. Pays a yield of 9%. Missed their growth objectives so he sold his holdings.
Jamie HorvatJamie Horvat
No
Unlock Rating
$6.850

Stock price when the opinion was issued

biotechnology pharmaceutical
WATCH

Futuremed Healthcare(FMD-T)

Dec 02, 2010
Distribute healthcare products primarily to retirement homes. Started to see more competition in the 2nd quarter and intensified in the 3rd quarter. Cut distributions once but may do another cut. He’ll wait for Q4 results.
Michael Simpson, CFAMichael Simpson, CFA
No
Unlock Rating
$6.390

Stock price when the opinion was issued

biotechnology pharmaceutical
COMMENT

Futuremed Healthcare(FMD-T)

Aug 25, 2010
Rarely sells after an earnings disappointment. Doesn’t think there is a structural problem with the business. They need to get some clarity on how they will transition into what is in effect a new business model where they will have a growth side.
Sandy McIntyreSandy McIntyre
Owned
Unlock Rating
$8.000

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Futuremed Healthcare(FMD-T)

Jul 07, 2010
Distributes supplies such as wound management, chairs, furniture, etc. to retirement homes. Well run. Have already cut their distributions. Trades at 6 times EBITDA.
Michael Simpson, CFAMichael Simpson, CFA
Owned
Unlock Rating
$9.200

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Futuremed Healthcare(FMD-T)

Dec 16, 2009
Conservative name trading at 10-11 times PE. Entrepreneurial management team with ownership in the company. Strong market share in the distribution business in healthcare and long term care facilities.
Jamie HorvatJamie Horvat
Owned
Unlock Rating
$9.350

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Futuremed Healthcare(FMD-T)

Jul 07, 2009
Distribution services for nursing homes. Generates a lot of free cash flow. Nursing homes are a growing market. Recession resistant. 13% distribution.
Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$7.310

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Futuremed Healthcare(FMD-T)

Feb 26, 2009
Distributor of medical products, mostly in Ontario. Just bought a Quebec company, which should grow revenues and margin expansion. 12% distribution is likely to be increased this year. Earnings per share should grow at 10%-20% also.
Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$7.960

Stock price when the opinion was issued

biotechnology pharmaceutical
COMMENT

Futuremed Healthcare(FMD-T)

May 05, 2008
Sells supplies to nursing homes, which is a growth industry long-term. Good management team.
Sandy McIntyreSandy McIntyre
No
Unlock Rating
$10.270

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Futuremed Healthcare(FMD-T)

Jan 21, 2008
He supplied provider to hospitals, nursing homes, et cetera. Healthcare sector so very protected in the event of a recession. Growing between 5% and 15% annually. Generates a lot of free cash flow. Distribution of around $.92 giving a 10% yield plus 10% growth.
Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$9.700

Stock price when the opinion was issued

biotechnology pharmaceutical
TRADE

Futuremed Healthcare(FMD-T)

Oct 19, 2007
It's appropriately priced. A fairly stable business. They do the distribution of medical products.
Chris Rankin, MBA, CFAChris Rankin, MBA, CFA
Unknown
Unlock Rating
$11.750

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Futuremed Healthcare(FMD-T)

Jan 04, 2007
Provide diapers/furniture to old age care facilities. Disappointed in some of their early earnings.
Michael Simpson, CFAMichael Simpson, CFA
No
Unlock Rating
$9.600

Stock price when the opinion was issued

biotechnology pharmaceutical
COMMENT

Futuremed Healthcare(FMD-T)

Dec 27, 2006
Sold his holdings. Really like the company because it was health care and not cyclical. Long-term outlook is really great. Good management. Price has dropped and he expects at some time he will own it again. Will look at the next quarter’s results.
Jean-Francois TardifJean-Francois Tardif
No
Unlock Rating
$9.580

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Futuremed Healthcare(FMD-T)

Aug 11, 2006
Basically distributes products to the long care sector. A play on the ageing population. 70/75% of its business is very stable. Has performed quite well. Also sells diagnostic equipment, which tends to be volatile. Expensive at the current level.
Garth JestleyGarth Jestley
No
Unlock Rating
$12.400

Stock price when the opinion was issued

biotechnology pharmaceutical
PAST TOP PICK

Futuremed Healthcare(FMD-T)

Jun 05, 2006
(A Top Pick Feb 15/06. Up 30%.) A very stable business distributing supplies to retirement homes. A lot of free cash flow.
Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$13.270

Stock price when the opinion was issued

biotechnology pharmaceutical
Showing 1 to 15 of 18 entries
Next PageNext Page

Futuremed Healthcare(FMD-T) Rating

Ranking : 1 out of 5

Star iconStar empty iconStar empty iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Futuremed Healthcare is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Futuremed Healthcare(FMD-T) Frequently Asked Questions

What is Futuremed Healthcare stock symbol?

Futuremed Healthcare is a OTC stock, trading under the symbol FMD-T on the (). It is usually referred to as or FMD-T

Is Futuremed Healthcare a buy or a sell?

In the last year, there was no coverage of Futuremed Healthcare published on Stockchase.

Is Futuremed Healthcare a good investment or a top pick?

Futuremed Healthcare was recommended as a Top Pick by on . Read the latest stock experts ratings for Futuremed Healthcare.

Why is Futuremed Healthcare stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Futuremed Healthcare worth watching?

0 stock analysts on Stockchase covered Futuremed Healthcare In the last year. It is a trending stock that is worth watching.

What is Futuremed Healthcare stock price?

On , Futuremed Healthcare (FMD-T) stock closed at a price of $.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Latest Buy Signals

CLS-T -3.91$123.45
NVDA-Q 4.58$111.01
PEP-Q -1.93$133.38
IBM-N 3.08$232.41
RMD-N -0.22$235.88

Today's Top Picks

KEY-T 0.18$42.62
BIP.UN… -0.15$39.97
POW-T -0.1$50.8
BBD.B-… 1.53$91.21
UNH-N -5.61$418.64

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

ARE-T -0.27$15.4
CVX-N -0.34$138.73
XOM-N -0.06$108.57
CNQ-T -0.01$40.68
TD-T -0.03$86.17

Most Recent Experts

Greg Newman

Scotia Wealth Management

Stockchase Insights

5i Research

Jim Cramer - Mad Money

CNBC

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

© Stockchase Inc.